N
Nagesh S. Anavekar
Researcher at University of Melbourne
Publications - 32
Citations - 5380
Nagesh S. Anavekar is an academic researcher from University of Melbourne. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 18, co-authored 31 publications receiving 4874 citations. Previous affiliations of Nagesh S. Anavekar include Brigham and Women's Hospital & Northern Hospital.
Papers
More filters
Journal ArticleDOI
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Nagesh S. Anavekar,John J.V. McMurray,Eric J. Velazquez,Scott D. Solomon,Lars Køber,Jean-Lucien Rouleau,Harvey D. White,Rolf Nordlander,Aldo P. Maggioni,Kenneth Dickstein,Steven L. Zelenkofske,Jeffrey D. Leimberger,Robert M. Califf,Marc A. Pfeffer +13 more
TL;DR: Even mild renal disease, as assessed by the estimated GFR, should be considered a major risk factor for cardiovascular complications after a myocardial infarction.
Journal ArticleDOI
State-of-the-Art PaperCardiorenal Syndrome
TL;DR: A new classification of the CRS with 5 subtypes that reflect the pathophysiology, the time-frame, and the nature of concomitant cardiac and renal dysfunction is presented to help physicians characterize groups of patients, provides the rationale for specific management strategies, and allows the design of future clinical trials with more accurate selection and stratification of the population under investigation.
Journal ArticleDOI
Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients
Scott D. Solomon,Nagesh S. Anavekar,Hicham Skali,John J.V. McMurray,Karl Swedberg,Salim Yusuf,Christopher B. Granger,Eric L. Michelson,Duolao Wang,Stuart J. Pocock,Marc A. Pfeffer +10 more
TL;DR: LVEF is a powerful predictor of cardiovascular outcome in heart failure patients across a broad spectrum of ventricular function, and once elevated to a range above 45%, ejection fraction does not further contribute to assessment of cardiovascular risk inheart failure patients.
Journal ArticleDOI
Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction
Scott D. Solomon,Hicham Skali,Nagesh S. Anavekar,Mikhail Bourgoun,Ståle Barvik,Jalal K. Ghali,J. Wayne Warnica,Margarita Khrakovskaya,J. Malcolm O. Arnold,Yuri Schwartz,Eric J. Velazquez,Robert M. Califf,John J.V. McMurray,Marc A. Pfeffer +13 more
TL;DR: Baseline echocardiographic measures of ejection fraction, end-diastolic volume, and infarct segment length were highly predictive of outcomes including total mortality, death or hospitalization for heart failure, or death or any cardiovascular event (heart failure, MI, stroke, resuscitated sudden death), even after adjustment for known covariates.
Journal ArticleDOI
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
Nagesh S. Anavekar,Hicham Skali,Mikhail Bourgoun,Jalal K. Ghali,Lars Køber,Aldo P. Maggioni,John J.V. McMurray,Eric J. Velazquez,Robert M. Califf,Marc A. Pfeffer,Scott D. Solomon +10 more
TL;DR: In this article, the authors found that decreased right ventricular systolic function is a major risk factor for death, sudden death, heart failure, and stroke after myocardial infarction.